Efficacy Testing

Global Efficacy Testing Market to Reach $796.7 Million by 2026

Efficacy test evaluates the effectiveness of the product through a series of tests, including safety test, toxicology test, and stability test, in order to get better quantitative values in addition to proof of efficacy and safety, after which the product becomes suitable for commercialization. Growth in the global market is being driven by regulations for the safety and efficacy of pharmaceutical products. Increasing support from governments across the world for pharmaceutical and biotechnology industries, coupled with increasing investments for research and development activities in these sectors contributes to market growth. Moreover, the growing application of antimicrobial efficacy testing for different types of medical devices, in cosmetic and pharmaceutical industries, and R&D investments in the life sciences space are anticipated to boost the market.

Amid the COVID-19 crisis, the global market for Efficacy Testing estimated at US$425.4 Million in the year 2020, is projected to reach a revised size of US$796.7 Million by 2026, growing at a CAGR of 10.7% over the analysis period. Consumables, one of the segments analyzed in the report, is projected to record a 11.4% CAGR and reach US$503.4 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 9.6% CAGR for the next 7-year period. Market growth is dominated by the consumables segment, which is attributed to continual demand for bulk procurement and regular purchases of consumables.

The U.S. Market is Estimated at $149.1 Million in 2021, While China is Forecast to Reach $107.7 Million by 2026

The Efficacy Testing market in the U.S. is estimated at US$149.1 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$107.7 Million by the year 2026 trailing a CAGR of 12.3% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.4% CAGR. The US dominates market growth due to heavy investments into research and development by several pharmaceutical vendors. Demand for efficacy testing in the US is further driven by stringent regulations for drug development, and increasing government funding for research activities in the area of life sciences. Growth in the Asia-Pacific region is attributed to the rising demand for pharmaceuticals in the region. Factors such as the rising geriatric population, growing incidence of chronic diseases, increasing consumer health awareness, and increased government expenditure on the region`s healthcare infrastructure as well as quality control safety testing outsourcing in the Asian countries.

Services Segment to Reach $112 Million by 2026

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$50.9 Million in the year 2020 will reach a projected size of US$98.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$9.5 Million by the year 2026, while Latin America will expand at a 11.2% CAGR through the analysis period.

Select Competitors (Total 70 Featured) -
  • Eurofins Scientific SE
  • Merck KGaA
  • WuXi AppTec
  • SGS S.A
  • bioMérieux
  • Charles River Laboratories Inc.
  • Pacific Biolabs Inc.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
A Prelude to Efficacy Testing
Global Efficacy Testing Market Poised for Steady Growth
US Dominates, Asia-Pacific to Witness Rapid Growth
Anti-microbial/Preservative Efficacy Testing to Register Rapid Growth
Disinfectant Efficacy Testing Dominates
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Importance of Preservative Efficacy Testing
Challenge Organisms
Testing Techniques
Challenges
Conclusion
Preservation Technique for Paraben-Free Cosmetics
Development of Alternative Techniques of Preservation
Adoption of Hurdle Technology
Preservative Systems in Liquid Dietary Supplements
Preservative Efficacy Test (PET) for Cosmetics
Efficacy Testing for Cosmetics
Techniques Employed for Demonstrating Effectiveness of Disinfectants
Categorization of Test Types
Surface Testing
Additional Tests Mandated for the Pharmaceuticals Industry by the USP
Contact Time Defined
Strong Rise in Pharmaceutical Sales to Drive Demand for Efficacy Testing
EXHIBIT 1: Global Prescription Drug Sales (In US$ Billion) for the Years 2017, 2019, 2021, 2023 & 2025
Rapid Growth of Generic Drugs Drives Demand for Pharma Efficacy Testing
EXHIBIT 2: Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2020 & 2025
Aging Population Propels the Demand for Ethicacy Testing in End-use Applications
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
Persistent Increase in Pharmaceutical R&D Bodes Well for Efficacy Testing
Rising Incidence of Chronic Diseases Fuels Demand for Efficacy Testing
Global Cancer Incidence by Region: 2018
Global Cancer Incidence by Type: 2018
EXHIBIT 10: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
EXHIBIT 3: Rising Diabetes Prevalence Presents Opportunity for Cell Harvesting: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for Disinfectant Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Disinfectant Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Disinfectant Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for Antimicrobial Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Antimicrobial Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Antimicrobial Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Pharmaceutical Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Pharmaceutical Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Pharmaceutical Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 22: World Current & Future Analysis for Cosmetics & Personal Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Cosmetics & Personal Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Cosmetics & Personal Care Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 25: World Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
Consumables Segment Leads the Market
III. MARKET ANALYSIS
UNITED STATES
TABLE 28: USA Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: USA Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: USA 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 31: USA Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: USA Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: USA 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 34: USA Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: USA Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: USA 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
CANADA
TABLE 37: Canada Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Canada Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: Canada 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 40: Canada Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Canada Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: Canada 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 43: Canada Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: Canada Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: Canada 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
JAPAN
TABLE 46: Japan Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Japan Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: Japan 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 49: Japan Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Japan Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Japan 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 52: Japan Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Japan Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Japan 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
CHINA
TABLE 55: China Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: China Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: China 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 58: China Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: China Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: China 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 61: China Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: China Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: China 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
EUROPE
TABLE 64: Europe Current & Future Analysis for Efficacy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 65: Europe Historic Review for Efficacy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Europe 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 67: Europe Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Europe Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Europe 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 70: Europe Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Europe Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Europe 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 73: Europe Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: Europe Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: Europe 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
FRANCE
TABLE 76: France Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: France Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: France 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 79: France Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: France Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: France 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 82: France Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: France Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: France 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
GERMANY
TABLE 85: Germany Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Germany Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Germany 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 88: Germany Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Germany Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Germany 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 91: Germany Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Germany Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Germany 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
ITALY
TABLE 94: Italy Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Italy Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Italy 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 97: Italy Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Italy Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Italy 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 100: Italy Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 101: Italy Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: Italy 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
UNITED KINGDOM
TABLE 103: UK Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: UK Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: UK 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 106: UK Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: UK Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: UK 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 109: UK Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: UK Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: UK 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
SPAIN
TABLE 112: Spain Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Spain Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: Spain 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 115: Spain Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: Spain Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: Spain 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 118: Spain Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: Spain Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: Spain 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
RUSSIA
TABLE 121: Russia Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: Russia Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: Russia 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 124: Russia Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: Russia Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 126: Russia 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 127: Russia Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Russia Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 129: Russia 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
REST OF EUROPE
TABLE 130: Rest of Europe Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Rest of Europe Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 132: Rest of Europe 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 133: Rest of Europe Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 134: Rest of Europe Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 135: Rest of Europe 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 136: Rest of Europe Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 137: Rest of Europe Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 138: Rest of Europe 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
ASIA-PACIFIC
TABLE 139: Asia-Pacific Current & Future Analysis for Efficacy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 140: Asia-Pacific Historic Review for Efficacy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 141: Asia-Pacific 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
TABLE 142: Asia-Pacific Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Asia-Pacific Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 144: Asia-Pacific 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 145: Asia-Pacific Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Asia-Pacific Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 147: Asia-Pacific 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 148: Asia-Pacific Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 149: Asia-Pacific Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 150: Asia-Pacific 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
AUSTRALIA
TABLE 151: Australia Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Australia Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 153: Australia 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 154: Australia Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Australia Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 156: Australia 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 157: Australia Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Australia Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 159: Australia 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
INDIA
TABLE 160: India Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: India Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 162: India 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 163: India Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: India Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 165: India 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 166: India Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 167: India Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 168: India 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
SOUTH KOREA
TABLE 169: South Korea Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 170: South Korea Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 171: South Korea 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 172: South Korea Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: South Korea Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 174: South Korea 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 175: South Korea Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: South Korea Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 177: South Korea 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
TABLE 178: Rest of Asia-Pacific Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Rest of Asia-Pacific Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 180: Rest of Asia-Pacific 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 182: Rest of Asia-Pacific Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 185: Rest of Asia-Pacific Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
LATIN AMERICA
TABLE 187: Latin America Current & Future Analysis for Efficacy Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 188: Latin America Historic Review for Efficacy Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 189: Latin America 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
TABLE 190: Latin America Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: Latin America Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 192: Latin America 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 193: Latin America Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: Latin America Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 195: Latin America 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 196: Latin America Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 197: Latin America Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 198: Latin America 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
ARGENTINA
TABLE 199: Argentina Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: Argentina Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 201: Argentina 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 202: Argentina Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 203: Argentina Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 204: Argentina 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 205: Argentina Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 206: Argentina Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 207: Argentina 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
BRAZIL
TABLE 208: Brazil Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 209: Brazil Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 210: Brazil 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 211: Brazil Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 212: Brazil Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 213: Brazil 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 214: Brazil Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 215: Brazil Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 216: Brazil 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
MEXICO
TABLE 217: Mexico Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 218: Mexico Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 219: Mexico 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 220: Mexico Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 221: Mexico Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 222: Mexico 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 223: Mexico Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 224: Mexico Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 225: Mexico 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
TABLE 226: Rest of Latin America Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 227: Rest of Latin America Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 228: Rest of Latin America 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 229: Rest of Latin America Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 230: Rest of Latin America Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 231: Rest of Latin America 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 232: Rest of Latin America Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 233: Rest of Latin America Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 234: Rest of Latin America 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
MIDDLE EAST
TABLE 235: Middle East Current & Future Analysis for Efficacy Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 236: Middle East Historic Review for Efficacy Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 237: Middle East 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
TABLE 238: Middle East Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 239: Middle East Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 240: Middle East 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 241: Middle East Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 242: Middle East Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 243: Middle East 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 244: Middle East Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 245: Middle East Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 246: Middle East 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
IRAN
TABLE 247: Iran Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 248: Iran Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 249: Iran 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 250: Iran Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 251: Iran Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 252: Iran 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 253: Iran Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 254: Iran Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 255: Iran 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
ISRAEL
TABLE 256: Israel Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 257: Israel Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 258: Israel 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 259: Israel Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 260: Israel Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 261: Israel 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 262: Israel Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 263: Israel Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 264: Israel 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
SAUDI ARABIA
TABLE 265: Saudi Arabia Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 266: Saudi Arabia Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 267: Saudi Arabia 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 268: Saudi Arabia Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 269: Saudi Arabia Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 270: Saudi Arabia 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 271: Saudi Arabia Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 272: Saudi Arabia Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 273: Saudi Arabia 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
TABLE 274: UAE Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 275: UAE Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 276: UAE 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 277: UAE Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 278: UAE Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 279: UAE 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 280: UAE Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 281: UAE Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 282: UAE 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
TABLE 283: Rest of Middle East Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 284: Rest of Middle East Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 285: Rest of Middle East 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 286: Rest of Middle East Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 287: Rest of Middle East Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 288: Rest of Middle East 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 289: Rest of Middle East Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 290: Rest of Middle East Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 291: Rest of Middle East 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
AFRICA
TABLE 292: Africa Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 293: Africa Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 294: Africa 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
TABLE 295: Africa Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 296: Africa Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 297: Africa 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
TABLE 298: Africa Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 299: Africa Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 300: Africa 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
IV. COMPETITION
Total Companies Profiled: 70

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook